Epilepsy in the Elderly: Scope of the Problem

International Review of Neurobiology

Volumn 81, Issue , 2007, Pages 1-14

  Leppik, Ilo E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

AGE DISTRIBUTION; AGED; DRUG INTERACTION; DRUG UTILIZATION; EPILEPSY; EUROPE; HUMAN; INCIDENCE; NURSING HOME; PREVALENCE; RETIREMENT; REVIEW; STATISTICS; UNITED STATES;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DRUG INTERACTIONS; DRUG UTILIZATION; EPILEPSY; EUROPE; HUMANS; INCIDENCE; NURSING HOMES; PREVALENCE; RETIREMENT; UNITED STATES;

EID: 34047228583     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(06)81001-9     Document Type: Review

References (40)

1. Amatniek J.C., Hauser W.A., DelCastillo-Castaneda C., Jacobs D.M., Marder K., Bell K., Albert M., Brandt J., and Stern Y. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 47 (2006) 867-872
2. Banh H.L., Burton M.E., and Sperling M.R. Interpatient and intrapatient variability in phenytoin protein binding. Ther. Drug Monit. 24 (2002) 379-385
3. Behrouz R., Heriaud L., and Benbadis S.R. Late-onset psychogenic nonepileptic seizures. Epilepsy Behav. 8 (2006) 649-650
4. Birnbaum A., Hardie N.A., Leppik I.E., Conway J.M., Bowers S.E., Lackner T., and Graves N.M. Variability of total phenytoin serum concentrations within elderly nursing home residents. Neurology 60 (2003) 555-559
5. Brodie M.J., Overstall P.W., and Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res. 37 (1999) 81-87
6. Cloyd J.C., Lackner T.E., and Leppik I.E. Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics. Arch. Fam. Med. 3 (1994) 589-598
7. Cloyd J., Hauser W., Towne A., Ramsay R., Mattson R., Gilliam F., and Walczak T. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res. 68 Suppl. 1 (2006) S39-S48
8. Cramer J.A., Leppik I.E., De Rue K., Edrich P., and Kramer G. Tolerability of levetiracetam in elderly patients with CNS disorders. Epilepsy Res. 56 (2003) 135-145
9. Dey A.N. Characteristics of elderly home health care users: Data from the 1994 National Home and Hospice Care Survey. Adv. Data 279 (1996) 1-12
10. Epilepsy Foundation of America. "Epilepsy, a Report to the Nation." (1999), Epilepsy Foundation, Landover, MD
11. Galimberti C.A., Magri F., Magnani B., Arbasino C., Cravello L., Marchioni E., and Tartara A. Antiepileptic drug use and epileptic seizures in elderly nursing home residents: A survey in the province of Pavia, Northern Italy. Epilepsy Res. 68 (2006) 1-8
12. Garrard J., Cloyd J., Gross C., Hardie N., Thomas L., Lackner T., Graves N., and Leppik I. Factors associated with antiepileptic drug use among elderly nursing home residents. J. Gerontol. A Biol. Sci. Med. Sci. 55 (2000) M384-M392
13. Garrard J., Harms S., Hardie N., Eberly L.E., Nitz N., Bland P., Gross C.R., and Leppik I.E. Antiepileptic drug use in nursing home admissions. Ann. Neurol. 54 (2003) 75-85
14. Gidal B.E., Garnett W.R., and Graves N. Epilepsy. In: DiPiro J.T., Talbert R.L., Yee G.C., Matzke G.R., Wells B.G., and Posey L.M. (Eds). "Pharmacotherapy: A Pathophysiologic Approach" (2002), McGraw-Hill, New York 1031-1060
15. Hauser W.A. Epidemiology of seizures in the elderly. In: Rowan A.J., and Ramsay R.E. (Eds). "Seizures and Epilepsy in the Elderly" (1997), Butterworth-Heinemann, Boston 7-18
16. Hauser W.A., and Hesdorffer D.C. "Epilepsy: Frequency, Causes, and Consequences." (1990), Demos, New York
17. Hauser W.A., Annegers J.F., and Kurland L.T. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 32 (1991) 429-445
18. Hauser W.A., Annegers J.F., and Rocca W.A. Descriptive epidemiology of epilepsy: Contributions of population-based studies from Rochester, Minnesota. Mayo Clin. Proc. 71 (1996) 576-586
19. Herd B., Wynne H., Wright P., James O., and Woodhouse K. The effect of age on glucuronidation and sulphation of paracetamol by human liver fractions. Br. J. Clin. Pharmacol. 32 (1991) 768-770
20. Hetzel L., and Smith A. The 65 years and over population: 2000 [Census 2000 Brief] (2001), U.S. Census Bureau, Washington, DC
21. Hussain S.A., Haut S.R., Lipton R.B., Derby C., Markowitz S.Y., and Shinnar S. Incidence of epilepsy in a racially diverse, community-dwelling, elderly cohort: Results from the Einstein aging study. Epilepsy Res. 71 (2006) 195-205
22. Huying F., Klimpe S., and Werhahn K.J. Antiepileptic drug use in nursing home residents: A cross-sectional, regional study. Seizure 15 (2006) 194-197
23. Kemper P., and Murtaugh C.M. Lifetime use of nursing home care. N. Engl. J. Med. 324 (1991) 595-600
24. Lackner T.E., Cloyd J.C., Thomas L.W., and Leppik I.E. Antiepileptic drug use in nursing home residents: Effect of age, gender, and comedication on patterns of use. Epilepsia 39 (1998) 1083-1087
25. Leppik I.E. "Contemporary Diagnosis and Management of the Patient With Epilepsy." (2000), Handbooks in Health Care, Newtown, PA
26. Leppik I.E. Antiepileptic drug trials in the elderly. Epilepsy Res. 68 (2006) 45-48
27. Leppik I.E. Introduction to the International Geriatric Epilepsy Symposium (IGES). Epilepsy Res. 68 Suppl. 1 (2006) 1-4
28. Moore S.R., and Jones J.K. Adverse drug reaction surveillance in the geriatric population: A preliminary view. In: Moore S.R., and Teal T.W. (Eds). "Geriatric Drug Use: Clinical & Social Perspectives" (1985), Pergamon Press, New York 70-77
29. Perucca E., Berlowitz D., Birnbaum A., Cloyd J.C., Garrard J., Hanlon J.T., Levy R.H., and Pugh M.J. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res. 68 Suppl. 1 (2006) S49-S63
30. Pugh M.J., Cramer J., Knoefel J., Charbonneau A., Mandell A., Kazis L., and Berlowitz D. Potentially inappropriate antiepileptic drugs for elderly patients with epilepsy. J. Am. Geriatr. Soc. 52 (2004) 417-422
31. Rochat P., Hallas J., Gaist D., and Friis M.L. Antiepileptic drug utilization: A Danish prescription database analysis. Acta Neurol. Scand. 104 (2001) 6-11
32. Rowan A.J., Ramsay R.E., Collins J.F., Pryor F., Boardman K.D., Uthman B.M., Spitz M., Frederick T., Towne A., Carter G.S., Marks W., Felicetta J., et al. New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 64 (2005) 1868-1873
33. Rumsfeld D. Department of Defense briefing (2002). http://www.defenselink.mil/transcripts/2002/t02122002_t212sdv2.html
34. Schachter S.C., Cramer G.W., Thompson G.D., Chaponis R.J., Mendelson M.A., and Lawhorne L. An evaluation of antiepileptic drug therapy in nursing facilities. J. Am. Geriatr. Soc. 46 (1998) 1137-1141
35. Sillanpaa M., Kalviainen R., Klaukka T., Helenius H., and Shinnar S. Temporal changes in the incidence of epilepsy in Finland: Nationwide study. Epilepsy Res. 71 (2006) 206-215
36. United Nations. "World Population Ageing: 1950-2050." (2001), United Nations Publications, New York
37. Verbeeck R.K., Cardinal J.A., and Wallace S.M. Effect of age and sex on the plasma binding of acidic and basic drugs. Eur. J. Clin. Pharmacol. 27 (1984) 91-97
38. Woodhouse K., and Herd B. The effect of age and gender on glucuronidation and sulphation in rat liver: A study using paracetamol as a model substrate. Arch. Gerontol. Geriatr. 16 (1993) 111-115
39. Woodhouse K.W., and Wynne H.A. Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly. Clin. Pharmacokinet. 15 (1988) 287-294
40. Wynne H.A., Cope L.H., Mutch E., Rawlins M.D., Woodhouse K.W., and James O.F. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 9 (1989) 297-301